Pharma Focus Asia

Puration Inc Confirms Cannabis Pharmaceutical Partnership Developments with Kali and Nouveau

Thursday, November 01, 2018

Puration, Inc today confirmed the developing joint venture agreement with Kali, Inc and Nouveau Life Pharmaceuticals, Inc. to develop cannabis pharmaceutical products.  Puration further confirms plans to host representatives from Kali and Nouvea in Dallas next week to finalize JV details.

“Puration is already in the wellness market and think our experience with the NCM Biotech Cannabis extraction patent will be valuable to the JV,” said Brian Shibley CEO of Puration. “I am pleased to be adding another dimension to the valuation of Puration for shareholders by tangentially entering the pharmaceuticals sector through a partnership while maintaining our internal focus on cannabis infused beverages.  I’m excited to soon announce details on the new beverage we are adding through acquisition.  That announcement will be coming by Friday, if not before, in a joint release from PURA and USMJ.  To be clear, the JV will be excluded from developing any beverages.  I’m not sure making a beverage would come up in a pharmaceutical endeavor, by Puration’s participation requires the JV partners agree that no beverage will be produced by the JV.  Puration is exclusively maintaining the cannabis beverage opportunity.”

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024